Our team has published a research flash on Cannara Biotech Inc. Cannara expanded its long-term international supply agreement with Curaleaf, lifting the potential contract value to $34M over a two-year term, up from $21M under the original July agreement (+62%). $LOVE 🔍 Read the report here: https://cutt.ly/xymPmqYv 📩 Subscribe here: https://cutt.ly/Je64fK2b 📰 Disclosure: Disseminated on Behalf of Cannara Biotech
68 views
0 Comments
No comments available.
Join the conversation with 500,000+ other investors 💸
Create an account to get access to everything Blossom has to offer!
📊 Personalized algorithm based on your investing style, experience level and interests
📈 Powerful portfolio and dividend tracking tools
👀 See what top creators and others in the community are investing in
